Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.
Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check8 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference4%
- Check15 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check51 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check71 days agoChange DetectedThe status has changed to 'Terminated' as business objectives have shifted, effective from July 24, 2024, following the completion noted on September 29, 2023.SummaryDifference2%
Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.